BC’s Nurse Practitioners Can Now Prescribe Treatment for Hepatitis C

PharmaCare now accepts Special Authority requests from NPs for HCV treatments! Best HCV treatment and elimination news we've heard in ages...this should help many more people get into BC's HCV treatment pipeline and make Elimination of Hepatitis C in BC by our goal of 2030 much more likely! As of October 30, 2019, Nurse Practitioners in BC have been permitted to fill out "Special Authority Requests for Hepatitis C treatment. These are the prescriptions ne

MAVIRET™ 8 week, pan-genotypic HCV treatment, good for CKD & cirrhosis, covered in Ontario

Finally, Maviret, AbbVie's hepatitis C drug, has made it through Canada's approval process and has been listed for coverage by Ontario's PharmaCare. We hope BC PharmaCare will also list it soon. "MAVIRET™ is the first and only 8-week, pan-genotypic treatment for chronic hepatitis C patients without cirrhosis and who are new to treatment (from: Decisions Resources Group. Hepatitis C virus: disease landscape & forecast 2016 and 2017)... MA...

The Week in Review: Jan 4, 2019 – Jan 11, 2019

Friday, Jan 11, 2019 News Recap: Winners of HepCBC’s November and December, 2019 Colouring Book Contest Announced HepCBC has a monthly contest aimed at current and former prisoners, but others are welcome to join. The prize is $50 worth of art supplies. Dramatic Series, UNSPEAKABLE about Canada’s Tainted Blood Scandal January 9, 2019, Toronto. A new CBC TV historical drama series, Unspeakable, started today which follows the lives of a couple he...

HepCBC Gets Thank-You Letter from Federal Government Agency, CADTH

Since 2011, HepCBC has provided patient group input to BC PharmaCare and, to the federal government, through CADTH – the Canadian Agency for Drugs and Technologies in Health. CADTH is one of the first ‘hoops’ new drugs and treatments must go through, while the various provincial Pharmacare plans are the final stage of approval, awarding patients coverage for the drug/treatment through the provincial health plan. You can see all the submissions HepCBC has m

The Week in Review: April 28 – May 11, 2018

Friday, May 11, 2018 News Recap: HBV: CADTH recommends that tenofovir alafenamide (TAF) be reimbursed for the treatment of chronic hepatitis B. The CADTH Canadian Drug Expert Committee (CDEC) recommends that tenofovir alafenamide (TAF) be reimbursed for the treatment of chronic hepatitis B in adults with compensated liver disease, if the following condition is met: CONDITION: The drug plan cost of TAF should not exceed that of the lowest-cost prepar...

BRIEF: CADTH recommends that tenofovir alafenamide (TAF) be reimbursed for the treatment of chronic hepatitis B

IN BRIEF: RECOMMENDATION The CADTH Canadian Drug Expert Committee (CDEC) recommends that tenofovir alafenamide (TAF) be reimbursed for the treatment of chronic hepatitis B in adults with compensated liver disease, if the following condition is met: CONDITION: The drug plan cost of TAF should not exceed that of the lowest-cost preparation of tenofovir disoproxil fumarate (TDF). Read more: https://www.cadth.ca/tenofovir-alafenamide  

The Week in Review: March 9 – March 16, 2018

Friday, March 16, 2018 News Recap: Canada: Treatment: Fantastic news from both BC and Quebec this last week:  All restrictions to treatment under the respective provincial PharmaCare plans have been removed!! See Chronic hepatitis C medication now available for all British Columbians, and Quebec Expands Patient Access to Chronic Hepatitis C Therapies. Grants Awarded to 13 Canadian Initiatives to Help Advance the Goal of Eliminating Chronic Hep...

The Week in Review: February 2 – February 9, 2018

Friday, February 9, 2018 News Recap: Epidemiology: CTAC Launches Campaign to End Hepatitis C in Canada. The Canadian Treatment Action Council (CTAC) has published a white paper entitled, "The time has come to eliminate hepatitis C in Canada," which summarizes the increasing gaps in Canada's response to the hepatitis C epidemic and identifies seven calls-to-action. #EASLmono: Expanding the conversation on hepatitis elimination. The recent European...

Attention Hepatitis B (HBV) Patients & Caregivers – Your Help Requested

Do you have HEPATITIS B or are you a CAREGIVER for someone with HBV? This is really important for you! An improved hepatitis B treatment will likely be covered by BC (Canada) PharmaCare soon, but first the BC government has requested HepCBC to submit a patient group review explaining whether hepatitis B patients want this new treatment, and why. SURVEY – ANSWER 5 QUESTIONS BELOW BY EMAIL or PHONE (English or Chinese 中文 ) HepCBC needs to hear your voice